A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

April 27, 2025

Study Completion Date

April 27, 2025

Conditions

Psoriasis

Interventions

DRUG

TQH3906 capsule

TQH3906 is a kinase inhibitor.

DRUG

TQH3906 placebo

Placebo Comparator

Trial Locations (1)

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors

lead

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

INDUSTRY

NCT06230588 - A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | Biotech Hunter | Biotech Hunter